Tuesday, March 3, 2015

Celgene's lung cancer drug Abraxane gets approval in Europe

… first-line treatment of non-small cell lung cancer (NSCLC) in adult patients. Manufactured … metastatic breast cancer, non-small cell lung cancer and pancreatic cancer in the …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)